Post Profile

Surgery timing after neoadjuvant chemoradiation in Stage IIIA NSCLC impacts OS

(International Association for the Study of Lung Cancer) The timing of surgery after neoadjuvant chemoradiation in patients with stage IIIA non-small cell lung cancer affects the overall survival of patients receiving trimodality therapy.
read more


Related Posts

Increased overall survival for advanced stage non-small cell lung cancer patients is associated with availability of less toxic

Academics / General Science : Science Codex

DENVER – A 10-year population-based study shows that increased availability of better systemic chemo- and targeted-therapies for patients with advanced non-small cell lung cancer (NSCLC) coincides with increased usage of these thera...

Marital status, race increase survival rate significantly for Stage III non-small cell lung cancer patients

Academics / General Science : Science Codex

A study of survival data for Stage III, non-small cell lung cancer (NSCLC) patients at the University of Maryland's Greenebaum Cancer Center in Baltimore indicates that marital status and race can significantly impact patient surviv...

Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments

Academics / General Science : Science Codex

San Francisco, September 16, 2014—A large, international analysis of patients with stage IV non-small cell lung cancer (NSCLC) indicates that a patient's overall survival (OS) rate can be related to factors including the timing of w...

Stage IIIA Non-Small Cell Lung Cancer Survival Rates Improved When Care Includes Four Specific Quality Measures

Health : Newswise Medical News

Analysis of data from the National Cancer Data Base (NCDB) demonstrates that the survival rates of patients with Stage IIIA NSCLC who underwent surgery increased more than three-fold for those who received four quality measures as p...

Hypofractionated Radiation Therapy Can Halve Treatment Time for Poor Performance Status Lung Cancer Patients

Health : Newswise Medical News

For patients with stage II and III non-small cell lung cancer (NSCLC) unable to receive standard treatments of surgery or chemoradiation (CRT), hypofractionated radiation therapy (RT) results in similar overall survival (OS) and pro...


Copyright © 2016 Regator, LLC